115 related articles for article (PubMed ID: 3242987)
21. Brain catecholamines in spontaneously hypertensive and DOCA-salt hypertensive rats.
Fujino K
Acta Med Okayama; 1984 Aug; 38(4):325-40. PubMed ID: 6149670
[TBL] [Abstract][Full Text] [Related]
22. Kainic acid lesions of paraventricular nucleus neurons reverse the elevated arterial pressure after aortic baroreceptor denervation in the rat.
Zhang TX; Ciriello J
Brain Res; 1985 Dec; 358(1-2):334-8. PubMed ID: 4075124
[TBL] [Abstract][Full Text] [Related]
23. Brain endogenous angiotensin II receptor type 2 (AT2-R) protects against DOCA/salt-induced hypertension in female rats.
Dai SY; Peng W; Zhang YP; Li JD; Shen Y; Sun XF
J Neuroinflammation; 2015 Mar; 12():47. PubMed ID: 25885968
[TBL] [Abstract][Full Text] [Related]
24. Deoxycorticosterone acetate-salt rats: hypertension and sympathoexcitation driven by increased NaCl levels.
O'Donaughy TL; Brooks VL
Hypertension; 2006 Apr; 47(4):680-5. PubMed ID: 16520400
[TBL] [Abstract][Full Text] [Related]
25. Activation of Orexin 1 Receptors in the Paraventricular Nucleus Contributes to the Development of Deoxycorticosterone Acetate-Salt Hypertension Through Regulation of Vasopressin.
Bigalke JA; Gao H; Chen QH; Shan Z
Front Physiol; 2021; 12():641331. PubMed ID: 33633591
[TBL] [Abstract][Full Text] [Related]
26. Lesions of the paraventricular nucleus alter the development of spontaneous hypertension in the rat.
Ciriello J; Kline RL; Zhang TX; Caverson MM
Brain Res; 1984 Sep; 310(2):355-9. PubMed ID: 6488025
[TBL] [Abstract][Full Text] [Related]
27. Atrial natriuretic factor content of brain nuclei in deoxycorticosterone acetate-salt hypertension in the rat.
Geiger H; Bahner U; Palkovits M; Hupe J; Heidland A
Clin Sci (Lond); 1989 Nov; 77(5):529-34. PubMed ID: 2531054
[TBL] [Abstract][Full Text] [Related]
28. Effect of chronic treatment with two different ET(A) selective endothelin receptor antagonists on blood pressure and small artery structure of deoxycorticosterone acetate (DOCA)-salt hypertensive rats.
Li JS; Turgeon A; Schiffrin EL
Am J Hypertens; 1998 May; 11(5):554-62. PubMed ID: 9633791
[TBL] [Abstract][Full Text] [Related]
29. Central attenuation of aortic baroreceptor reflex in prehypertensive DOCA-salt-loaded rats.
Nakamura Y; Takeda K; Nakata T; Hayashi J; Kawasaki S; Lee LC; Sasaki S; Nakagawa M; Ijichi H
Hypertension; 1988 Sep; 12(3):259-66. PubMed ID: 3169941
[TBL] [Abstract][Full Text] [Related]
30. Chronic central potassium infusion prevents deoxycorticosterone-salt hypertension in rats.
Klarr SA; Keep RF; Betz AL
Am J Physiol; 1995 Feb; 268(2 Pt 2):H646-52. PubMed ID: 7864190
[TBL] [Abstract][Full Text] [Related]
31. Cardiac sympathetic hyperinnervation in deoxycorticosterone acetate-salt hypertensive rats.
Lee TM; Chen CC; Chang NC
Clin Sci (Lond); 2012 Oct; 123(7):445-57. PubMed ID: 22507072
[TBL] [Abstract][Full Text] [Related]
32. Resting Afferent Renal Nerve Discharge and Renal Inflammation: Elucidating the Role of Afferent and Efferent Renal Nerves in Deoxycorticosterone Acetate Salt Hypertension.
Banek CT; Knuepfer MM; Foss JD; Fiege JK; Asirvatham-Jeyaraj N; Van Helden D; Shimizu Y; Osborn JW
Hypertension; 2016 Dec; 68(6):1415-1423. PubMed ID: 27698066
[TBL] [Abstract][Full Text] [Related]
33. Brain endoplasmic reticulum stress mechanistically distinguishes the saline-intake and hypertensive response to deoxycorticosterone acetate-salt.
Jo F; Jo H; Hilzendeger AM; Thompson AP; Cassell MD; Rutkowski DT; Davisson RL; Grobe JL; Sigmund CD
Hypertension; 2015 Jun; 65(6):1341-8. PubMed ID: 25895586
[TBL] [Abstract][Full Text] [Related]
34. Brain ACE2 overexpression reduces DOCA-salt hypertension independently of endoplasmic reticulum stress.
Xia H; de Queiroz TM; Sriramula S; Feng Y; Johnson T; Mungrue IN; Lazartigues E
Am J Physiol Regul Integr Comp Physiol; 2015 Mar; 308(5):R370-8. PubMed ID: 25519733
[TBL] [Abstract][Full Text] [Related]
35. 5-HT2B-receptor antagonist LY-272015 is antihypertensive in DOCA-salt-hypertensive rats.
Watts SW; Fink GD
Am J Physiol; 1999 Mar; 276(3):H944-52. PubMed ID: 10070078
[TBL] [Abstract][Full Text] [Related]
36. Angiotensin type 1a receptors in the subfornical organ are required for deoxycorticosterone acetate-salt hypertension.
Hilzendeger AM; Cassell MD; Davis DR; Stauss HM; Mark AL; Grobe JL; Sigmund CD
Hypertension; 2013 Mar; 61(3):716-22. PubMed ID: 23266541
[TBL] [Abstract][Full Text] [Related]
37. Changes in Fos expression in various brain regions during deoxycorticosterone acetate treatment: relation to salt appetite, vasopressin mRNA and the mineralocorticoid receptor.
Pietranera L; Saravia FE; McEwen BS; Lucas LL; Johnson AK; De Nicola AF
Neuroendocrinology; 2001 Dec; 74(6):396-406. PubMed ID: 11752896
[TBL] [Abstract][Full Text] [Related]
38. Chronic blockade of endogenous atrial natriuretic polypeptide (ANP) by monoclonal antibody against ANP accelerates the development of hypertension in spontaneously hypertensive and deoxycorticosterone acetate-salt-hypertensive rats.
Itoh H; Nakao K; Mukoyama M; Yamada T; Hosoda K; Shirakami G; Morii N; Sugawara A; Saito Y; Shiono S
J Clin Invest; 1989 Jul; 84(1):145-54. PubMed ID: 2544622
[TBL] [Abstract][Full Text] [Related]
39. Importance of renal sympathetic tone in the development of DOCA-salt hypertension in the rat.
Katholi RE; Naftilan AJ; Oparil S
Hypertension; 1980; 2(3):266-73. PubMed ID: 6993358
[TBL] [Abstract][Full Text] [Related]
40. Centrally induced vasopressor responses to ouabain in DOCA-salt hypertensive rats.
Takahashi H; Okabayashi H; Matsuzawa M; Suga K; Ikegaki I; Yoshimura M; Ijichi H
Cardiovasc Res; 1987 Jun; 21(6):439-46. PubMed ID: 2820576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
